4.7 Article

Evidence for Altered Phosphoinositide Signaling-Associated Molecules in the Postmortem Prefrontal Cortex of Patients with Schizophrenia

Journal

Publisher

MDPI
DOI: 10.3390/ijms22158280

Keywords

phosphoinositides; phosphatidylinositol 4-kinase alpha; protein kinase B; schizophrenia; postmortem brain; prefrontal cortex; multiplex immunoassay

Funding

  1. Strategic Research Program for Brain Sciences from AMED [JP20dm0107107, JP20dm0107104, JP21dm020707]
  2. Ministry of Education, Culture, Sports, Science, and Technology of Japan [19K08053, 19H05223, JP21H00180]
  3. Japan Society for the Promotion of Science [25861022]
  4. Collaborative Research Project of Brain Research Institute, Niigata University [201917]
  5. Grants-in-Aid for Scientific Research [19H05223, 19K08053, 25861022] Funding Source: KAKEN

Ask authors/readers for more resources

Phosphoinositides play crucial roles in the brain functioning, and their metabolic pathways have been shown to be associated with the pathophysiology of schizophrenia. This study investigated the expression levels of PI signaling-associated proteins in the postmortem brains of schizophrenia patients and found lower expression of PIK4CA and higher expression of Akt in the prefrontal cortex of these patients. These results suggest that PIK4CA may be involved in the mechanism underlying the pathogenesis of schizophrenia.
Phosphoinositides (PIs) play important roles in the structure and function of the brain. Associations between PIs and the pathophysiology of schizophrenia have been studied. However, the significance of the PI metabolic pathway in the pathology of schizophrenia is unknown. We examined the expression of PI signaling-associated proteins in the postmortem brain of schizophrenia patients. Protein expression levels of phosphatidylinositol 4-phosphate 5-kinase type-1 gamma (PIP5K1C), phosphatidylinositol 4-kinase alpha (PIK4CA, also known as PIK4A), phosphatase and tensin homolog deleted from chromosome 10 (PTEN), protein kinase B (Akt), and glycogen synthase kinase 3 beta (GSK3 beta) were measured using enzyme-linked immunosorbent assays and multiplex fluorescent bead-based immunoassays of the prefrontal cortex (PFC) of postmortem samples from 23 schizophrenia patients and 47 normal controls. We also examined the association between PIK4CA expression and its genetic variants in the same brain samples. PIK4CA expression was lower, whereas Akt expression was higher, in the PFC of schizophrenia patients than in that of controls; PIP5K1C, PTEN, and GSK3 beta expression was not different. No single-nucleotide polymorphism significantly affected protein expression. We identified molecules involved in the pathology of schizophrenia via this lipid metabolic pathway. These results suggest that PIK4CA is involved in the mechanism underlying the pathogenesis of schizophrenia and is a potential novel therapeutic target.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available